Search Results
Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma
Carfilzomib, Lenalidomide and Dex (KRd) After ASCT Results in High Rates of MRD Negativity
Isatuximab, Carfilzomib, Lenalidomide, and Dex (Isa-KRd) in Pts with High-Risk Newly Diagnosed MM
Daratumumab, Carfilzomib, Lenalidomide & Dexamethasone w/ MRD Res. Adapted Therapy in Newly Diag. MM
KRd vs VRd as Induction Therapy in Newly Diagnosed High-Risk Multiple Myeloma
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma
The Myeloma XI trial: adding carfilzomib to cyclophosphamide, lenalidomide, and dexamethasone
Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in ...
Combination of Isatuximab, Carfilzomib, Lenalidomide, Dex in Myeloma | Elizabeth O'Donnell | #ASH24
Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma
Once-weekly carfilzomib combined with lenalidomide and dexamethasone for multiple myeloma
Carfilzomib 2x Weekly in Combination with Dex and Daratumumab Vs Dara with Bortezomib and Dex
